Pratap Chokka Selected Research

Pratap Chokka Research Topics

8	Major Depressive Disorder (Major Depressive Disorders) 03/2024 - 01/2008
2	Treatment-Resistant Depressive Disorder 01/2022 - 10/2019
2	Neurobehavioral Manifestations 12/2019 - 01/2019
1	Mood Disorders (Mood Disorder) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Cognitive Dysfunction 01/2019
1	Substance-Related Disorders (Drug Abuse) 09/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007
1	Obesity 09/2007
1	Social Phobia 02/2007
1	Panic Disorder (Panic Attack) 01/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2006

5	VortioxetineIBA 01/2021 - 01/2019
2	propylene diquat (PDQ(+))IBA 12/2019 - 01/2019
1	brexpiprazoleIBA 03/2024
1	Ketamine FDA LinkGeneric 01/2022
1	EsketamineIBA 10/2019
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2019
1	Methylphenidate (Ritalin)FDA LinkGeneric 09/2012
1	Escitalopram FDA Link 01/2008
1	Dobutamine FDA LinkGeneric 10/2007
1	Antipsychotic Agents (Antipsychotics)IBA 09/2007
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2007
1	nefazodone (Serzone)FDA LinkGeneric 02/2007
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2007
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 01/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2007
1	Antidepressive Agents (Antidepressants)IBA 11/2006

1	Therapeutics 12/2014